We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$84.2B
1-Year Est. Return
55.88%
This Fund
S&P 500
This Quarter
Est. Return
+1.38%
1 Year Est. Return
+55.88%
3 Year Est. Return
+186.68%
5 Year Est. Return
+269.34%
10 Year Est. Return
+1,086.67%
AUM
$23.9B
AUM Growth
-$469M
(-1.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
1,935
New
209
Increased
532
Reduced
683
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$392M |
| 2 |
BP
BP
|
+$158M |
| 3 |
General Motors
GM
|
+$152M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$148M |
| 5 |
Amdocs
DOX
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$102M |
| 2 |
Marriott International
MAR
|
+$95.6M |
| 3 |
Fortinet
FTNT
|
+$94.9M |
| 4 |
Cardinal Health
CAH
|
+$91.3M |
| 5 |
Apple
AAPL
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Staples | 10.22% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTRPA
1101
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $328K | ﹤0.01% |
672,525
-33,471
| -5% | -$21.7K |
|
1102
Spero Therapeutics
SPRO
$71.2M
| $327K | ﹤0.01% |
272,024
+98,485
| +57% | +$136K |
|
1103
Century Casinos
CNTY
$34.9M
| $326K | ﹤0.01% |
63,718
-112,895
| -64% | -$761K |
|
1104
BioMarin Pharmaceuticals
BMRN
$13.3B
| $325K | ﹤0.01% |
3,682
+1,660
| +82% | +$148K |
|
|
VBNK
1105
VersaBank
VBNK
$645M
| $320K | ﹤0.01% |
41,005
+8,071
| +25% | +$65.4K |
|
1106
Dominion Energy
D
$60.2B
| $318K | ﹤0.01% |
7,127
+162
| +2% | +$8.04K |
|
1107
Sensus Healthcare
SRTS
$51.9M
| $317K | ﹤0.01% |
115,055
-233,902
| -67% | -$715K |
|
1108
Fortress Biotech
FBIO
$99M
| $311K | ﹤0.01% |
71,702
| – | – |
|
1109
Columbus McKinnon
CMCO
$550M
| $310K | ﹤0.01% |
8,913
+6,853
| +333% | +$261K |
|
|
QXO
1110
QXO Inc
QXO
$16B
| $310K | ﹤0.01% |
11,654
| – | – |
|
|
CFLT
1111
DELISTED
Confluent
CFLT
| $306K | ﹤0.01% |
10,423
+2,200
| +27% | +$73.7K |
|
1112
ArcelorMittal
MT
$55.1B
| $305K | ﹤0.01% |
+12,208
| New | +$325K |
|
|
MIXT
1113
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $305K | ﹤0.01% |
56,485
-3,067
| -5% | -$19.7K |
|
1114
Dream Finders Homes
DFH
$1.35B
| $303K | ﹤0.01% |
13,703
+5,394
| +65% | +$140K |
|
1115
Dianthus Therapeutics
DNTH
$6.12B
| $303K | ﹤0.01% |
22,299
-6,307
| -22% | -$79.5K |
|
1116
Ampco-Pittsburgh
AP
$190M
| $301K | ﹤0.01% |
114,997
| – | – |
|
1117
National Beverage
FIZZ
$2.94B
| $301K | ﹤0.01% |
6,409
-1,692
| -21% | -$85.3K |
|
1118
Expro Ltd
XPRO
$2.1B
| $301K | ﹤0.01% |
+12,960
| New | +$292K |
|
1119
DXC Technology
DXC
$1.79B
| $299K | ﹤0.01% |
14,362
-12,141
| -46% | -$279K |
|
1120
Tiptree Inc
TIPT
$678M
| $298K | ﹤0.01% |
17,810
-9,043
| -34% | -$144K |
|
1121
Morgan Stanley
MS
$343B
| $297K | ﹤0.01% |
3,661
-205,940
| -98% | -$17.9M |
|
1122
Pixelworks
PXLW
$45.6M
| $294K | ﹤0.01% |
21,842
+1,079
| +5% | +$18.6K |
|
1123
Tidewater
TDW
$4.53B
| $294K | ﹤0.01% |
4,146
-1,672
| -29% | -$106K |
|
1124
Canadian Natural Resources
CNQ
$98.1B
| $292K | ﹤0.01% |
9,000
-14,600
| -62% | -$446K |
|
1125
General Dynamics
GD
$106B
| $292K | ﹤0.01% |
1,323
-4,424
| -77% | -$979K |
|
Similar funds
Acadian Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Acadian Asset Management held 1,935 positions worth $23.9B, down 1.9% from $24.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Acadian Asset Management's Q3 2023 filing shows 209 new, 532 increased, 683 reduced and 293 closed positions. Its largest new stake was Amdocs: 1,147,499 shares worth $96.9M. The largest sale was GSK, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Acadian Asset Management's largest Q3 2023 buy was Amdocs: 1,147,499 shares worth $96.9M.
- Acadian Asset Management added most to Stellantis in Q3 2023, an estimated $392M increase.
- Acadian Asset Management's biggest Q3 2023 reduction was GSK, cutting an estimated $102M.
- Acadian Asset Management fully exited KE Holdings in Q3 2023, selling an estimated $49.5M.
- Acadian Asset Management's ten largest holdings make up 21% of its $23.9B portfolio in Q3 2023.
- Acadian Asset Management opened 209 new positions and closed 293 in Q3 2023.
- Acadian Asset Management's portfolio value fell 1.9% quarter-over-quarter to $23.9B.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.